Seer
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3800 Bridge Pkwy Ste 102, Redwood City, ...Phone Number
(833) 254-7337Website
seer.bioRevenue
$15.2 MillionStock Symbol
SEERIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
2
1
About Seer
Founded in 2017, Seer is a life sciences company focused on capturing deep molecular insights from the proteome to enable novel insights and breakthroughs in the understanding of biology and disease. They are based in Redwood City, California.Explore more
Seer Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Seer your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Seer, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Seer had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Seer
Earning: See what the market has to say on Seer recently announced quarterly report
Check out if Seer is spiking on competitors!
Check if Seer has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Seer launches new products
Funding: Get notified immidiatlly once Seer has new funding data
Recommended Actions
Find VP level buyers at Seer
Find 3 more new buyers
Compare Similar Companies to Seer
Compare insights from companies similar to Seer, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Seer is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Seer is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Seer.
Seer financials insights
Gather financial insights about Seer, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$6M
2018
Series B
$36M
2019
Series C
$17.5M
Series D
$55M
2020
Multiple Rounds
$365M
Seer Tech Stack
A closer look at the technologies used by Seer
See more technologies
Most Recent Scoops
Earnings
reported total gross profit of $1.5 million for Q2 2026, representing a gross margin of 49%, compared to 52% in Q2 2025, and a 1,300 basis point improvement sequentially, with the company reiterating its long-term gross margin target of 70% to 75% at scale.
Earnings, Finance
Person-Based
Events
Open Position
Person-Based
Medical Research
Person-Based
Medical Research
Seer News & Media
Seer Announces CFO Transition
REDWOOD CITY, Calif., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that David Horn, the Company’s President, Chief Financial Officer and Treasurer, will depart Seer effective October 1, 2026, to pursue a new opportunity at a private company.Seer Surpasses 100 Peer-Reviewed Customer Publications, Validating a New Era of Deep Proteomics at Scale
Six years after Seer’s foundational Nature Communications paper, researchers across three continents have built a growing body of evidence demonstrating the power of deep, unbiased proteomics across genetics, aging, disease biology and population health Six years after Seer’s foundational Nature Communications paper, researchers across three continents have built a growing body of evidence demonstrating the power of deep, unbiased proteomics across genetics, aging, disease biology and populationSeer, Inc. (SEER) Q2 2026 Earnings Call Transcript
Seer, Inc. (SEER) Q2 2026 Earnings Call August 11, 2026 4:30 PM EDTCompany ParticipantsOmid Farokhzad - Founder, CEO, & Chair of the Board of...Seer Reports Second Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
REDWOOD CITY, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial results for the quarter ended June 30, 2026.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Seer
Sign Up For FreeTo access detailed company insights
Founded in 2017, Seer is a life sciences company focused on capturing deep molecular insights from the proteome to enable novel insights and breakthroughs in the understanding of biology and disease. They are based in Redwood City, California.... Read More
